© Copyright 2025 American Medical Association. All rights reserved.
The CPT® Code 0578T refers to the process of conducting remote interrogation device evaluations for a substernal lead implantable cardioverter-defibrillator (ICD) system over a period of up to 90 days. This procedure involves the use of telemetric communication to assess the functionality of the ICD system, which includes the evaluation of the device's leads, battery status, and programmed parameters. During the interrogation, a physician or other qualified healthcare professional reviews the data collected from the device to ensure it is operating correctly and to monitor the patient's cardiac health. This includes analyzing electrocardiogram (ECG) recordings for any signs of arrhythmia, as well as reviewing stored data that may include previous events and comparing them to current findings. The evaluation also encompasses the assessment of various cardiac events, such as arrhythmias and ectopic beats, and the device's ability to sense and capture the cardiac rhythm appropriately. Additionally, any alerts generated by the ICD are examined, and the patient is informed of the findings through a comprehensive written report. This code is specifically used for the interim analysis, reviews, and reports conducted by a physician or qualified healthcare professional, distinguishing it from other related codes that may pertain to technical support or data acquisition performed by technicians.
© Copyright 2025 Coding Ahead. All rights reserved.
The remote interrogation device evaluation using CPT® Code 0578T is indicated for patients who have a substernal lead implantable cardioverter-defibrillator system. This procedure is typically performed to monitor the device's functionality and assess the patient's cardiac health over a period of up to 90 days. The indications for this evaluation may include:
The procedure for CPT® Code 0578T involves several key steps to ensure a comprehensive evaluation of the implantable cardioverter-defibrillator system. These steps include:
Following the remote interrogation device evaluation, the patient may be advised on any necessary follow-up actions based on the findings of the report. This may include scheduling additional evaluations or in-person visits if any issues are identified that require further investigation or intervention. The healthcare professional will provide the patient with information regarding their cardiac health and any changes that may need to be made to their treatment plan. Continuous monitoring may be recommended, especially if any arrhythmias or device-related issues are detected during the evaluation. The written report serves as a critical document for ongoing patient management and should be retained in the patient's medical records for future reference.
Short Descr | REM INTERROG DEV ICDS PHYS | Medium Descr | REM INTERROG DEV EVAL SS LD ICDS <90D PHY/QHP | Long Descr | Interrogation device evaluation(s) (remote), up to 90 days, substernal lead implantable cardioverter-defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | Status Code | Carriers Price the Code | Global Days | YYY - Carrier Determines Whether Global Concept Applies | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Not Billable to the MAC | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. |
Date
|
Action
|
Notes
|
---|---|---|
2020-01-01 | Added | Code added. |
Get instant expert-level medical coding assistance.